actg019 | R Documentation |
A data set from the AIDS clinical trial ACTG019 (https://clinicaltrials.gov/ct2/show/NCT00000736) comparing zidovudine (AZT) with a placebo in adults with asymptomatic HIV infection. The study results were described in Volberding et al. (1990) doi:10.1056/NEJM199004053221401.
actg019
A data frame with 822 rows and 5 variables:
outcome variable with 1 indicating death, development of AIDS or AIDS-related complex (ARC) and 0 otherwise
patient age in years
treatment indicator, 0 = placebo, 1 = AZT
race indicator, 0 = non-white, 1 = white
CD4 cell count
Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Murphy, R. L., Hardy, W. D., Soeiro, R., Fischl, M. A., Bartlett, J. G., Merigan, T. C., Hyslop, N. E., Richman, D. D., Valentine, F. T., Corey, L., and the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases (1990). Zidovudine in asymptomatic human immunodeficiency virus infection. New England Journal of Medicine, 322(14), 941–949.
Chen, M.-H., Ibrahim, J. G., and Yiannoutsos, C. (1999). Prior elicitation, Variable Selection and Bayesian computation for Logistic Regression Models. Journal of the Royal Statistical Society Series B: Statistical Methodology, 61(1), 223–242.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.